The Journal of Immunology, Vol 150, Issue 4 1429-1436, Copyright © 1993 by American Association of Immunologists

ARTICLES

MHC class I expression on tumor targets inhibits natural killer cell- mediated cytotoxicity without interfering with target recognition

DS Kaufman, RA Schoon and PJ Leibson
Department of Immunology, Mayo Clinic and Foundation, Rochester, MN 55905.

NK cell-mediated killing is inversely proportional to the amount of MHC class I expression on certain tumor targets. Two hypotheses have been proposed to explain why class I-bearing targets are more resistant to NK cell-mediated lysis: 1) the presence of class I prevents NK cell recognition of a triggering molecule on the target cell surface, or 2) class I recognition transmits a separate inhibitory signal to the NK cell. To differentiate between these potential mechanisms, we have used cloned human CD16+/CD3- NK cells, the class I-deficient cell line C1R, and C1R cells expressing high levels of transfected HLA class I gene products. If class I expression blocks NK cell recognition of the targets, then proximal cell signaling events such as phospholipase C- mediated hydrolysis of membrane phosphoinositides should be decreased in the NK cells interacting with the class I transfectants. However, we found that increases in the level of target cell class I expressions did not decrease phosphoinositide turnover or calcium signaling in NK cells. We also examined the effect of treating HLA-transfected C1R cells with mAb specific for the transfected MHC class I gene product. If class I expression has a negative regulatory influence on NK cell activation, then treating the targets with anti-HLA mAb should block the transmission of this negative signal. Consistent with this notion, addition of anti-HLA mAb (either whole Ig or F(ab')2 fragments) led to increased lysis of the class I-transfected targets. In contrast, addition of isotype-matched mAb specific for other cell surface markers did not alter sensitivity to lysis. All of these results suggest that MHC class I expression on target cells can initiate inhibitory signals in NK cells without blocking access to target structures.

This article has been cited by other articles:

				D. A. Alvarez-Arias and K. S. Campbell Protein Kinase C Regulates Expression and Function of Inhibitory Killer Cell Ig-Like Receptors in NK Cells J. Immunol., October 15, 2007; 179(8): 5281 - 5290. [Abstract] [Full Text] [PDF]

				C. S. Chang, L. Brossay, M. Kronenberg, and K. P. Kane The Murine Nonclassical Class I Major Histocompatibility Complex-like CD1.1 Molecule Protects Target Cells from Lymphokine-activated Killer Cell Cytolysis J. Exp. Med., February 1, 1999; 189(3): 483 - 491. [Abstract] [Full Text] [PDF]

				B. Das, M. O. Mondragon, S.-Z. Tao, and A. J. Norin Preferential Interaction of a Novel Tumor Surface Protein (p38.5) with Naive Natural Killer Cells J. Exp. Med., May 19, 1997; 185(10): 1735 - 1742. [Abstract] [Full Text] [PDF]

				N. M. Valiante, J. H. Phillips, L. L. Lanier, and P. Parham Killer Cell Inhibitory Receptor Recognition of Human Leukocyte Antigen (HLA) Class I Blocks Formation of a pp36/PLC-gamma Signaling Complex in Human Natural Killer (NK) Cells J. Exp. Med., December 15, 1996; 184(6): 2243 - 2250. [Abstract] [Full Text] [PDF]